CREFX
Price
$19.54
Change
+$0.03 (+0.15%)
Updated
Jul 9 closing price
Net Assets
9.61B
PJEAX
Price
$18.39
Change
+$0.03 (+0.16%)
Updated
Jul 9 closing price
Net Assets
378.43M
Interact to see
Advertisement

CREFX vs PJEAX

CREFX vs PJEAX Comparison Chart in %
View a ticker or compare two or three
VS
CREFX vs. PJEAX commentary
Jul 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CREFX is a Hold and PJEAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CREFX has more cash in the bank: 9.61B vs. PJEAX (378M). CREFX pays higher dividends than PJEAX: CREFX (2.76) vs PJEAX (1.55). CREFX was incepted earlier than PJEAX: CREFX (9 years) vs PJEAX (16 years). PJEAX (1.70) is less costly to investors than CREFX (0.75). PJEAX is a more actively managed with annual turnover of: 84.00 vs. CREFX (27.00). CREFX has a lower initial minimum investment than PJEAX: CREFX (0) vs PJEAX (1000). PJEAX annual gain was more profitable for investors over the last year : 22.14 vs. CREFX (13.58). PJEAX return over 5 years is better than : 19.02 vs. CREFX (12.13).
CREFXPJEAXCREFX / PJEAX
Total Expense Ratio0.751.2560%
Annual Report Gross Expense Ratio0.751.7044%
Fund Existence9 years16 years-
Gain YTD14.09219.29473%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets9.61B378M2,542%
Annual Yield % from dividends2.761.55179%
Returns for 1 year13.5822.1461%
Returns for 3 years34.7646.3375%
Returns for 5 years12.1319.0264%
Returns for 10 yearsN/A46.79-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGGAX69.65N/A
N/A
ClearBridge International Growth A
JAAGX83.25N/A
N/A
Janus Henderson VIT Enterprise Instl
IHSIX29.32N/A
N/A
Hartford Small Company I
EMWLX26.12N/A
N/A
Lord Abbett Emerging Markets Equity R6
INDSX15.12N/A
N/A
Kotak India Equity Fund Class II